Advertisement

Near-Clinical Applications of Laser Scanning Cytometry

  • David A. Rew
  • Gerrit Woltmann
  • Davinder Kaur
Part of the Methods in Molecular Biology™ book series (MIMB, volume 319)

Abstract

Biological samples from human tissues are characterized by complexity and heterogeneity. The ability to make rapid, reliable, quantitative fluorochromatic measurements on clinical samples allows the development of new and practical assays that could influence diagnosis and treatment in a variety of clinical applications. Laser scanning cytometry (LSC) is a very versatile and adaptable technology that allows for the quantitative analysis of cell samples that are unsuitable for flow cytometry by virtue of their presentation and context. Crucially, it allows the direct visualization of cells and rare events and the correlation of imagery with fluorochromatic measurements. In this chapter, we describe early experiments in the study of cytotoxic drug uptake and resistance in human tumor cells and in the study of sputum cells from asthmatic patients, which harness the specific capabilities of LSC to practical clinical problems.

Key Words

Laser scanning cytometry drug resistance cancer doxorubicin breast cancer asthma sputum eosinophils cytospins bronchial epithelium cells 

References

  1. 1.
    Kamentsky, L. A. and Kamentsky, L. D. (1991) Microscope based multiparameter laser scanning cytometer which yields data comparable to flow cytometry data. Cytometry 12, 381–387.PubMedCrossRefGoogle Scholar
  2. 2.
    Kamentsky, L. A., Kamentsky, L. D., Fletcher, J. A., Kurose, A., and Sasaki, K. (1997) Methods for automatic multiparameter analysis of fluorescence in situ hybridised specimens with a laser scanning cytometer. Cytometry 27, 117–125.PubMedCrossRefGoogle Scholar
  3. 3.
    Styles, J. A. and Rew, D. A. (2001) Automation of mouse micronucleus genotoxicity assays by laser scanning cytometry. Cytometry 44, 153–155.PubMedCrossRefGoogle Scholar
  4. 4.
    Clatch, R. J., Foreman, J. R., and Walloch, J. L. (1998a) Simplified immunophenotypic analysis by laser scanning cytometry. Cytometry 34, 1, 3–16.CrossRefGoogle Scholar
  5. 5.
    Clatch, R. J. and Foreman, J. R. (1998b) Five color immunophenotyping plus DNA content by laser scanning cytometry. Cytometry 34, 1, 36–38.CrossRefGoogle Scholar
  6. 6.
    Sasaki, K., Kurose, A., Miura, Y., Sato, T., and Ikeda, E. (1996) DNA ploidy analysis by laser scanning cytometry in colorectal cancers, and comparison with flow cytometry. Cytometry 23, 106–109.PubMedCrossRefGoogle Scholar
  7. 7.
    Reeve, L. and Rew, D.A. (1997) New technology in the analytical cell sciences: the laser scanning cytometer. Eur. J. Surg. Oncol. 23, 445–450.PubMedCrossRefGoogle Scholar
  8. 8.
    Woltmann, G., Wardlaw, A. J., and Rew, D. A. (1998) Image analysis enhancement of the laser scanning cytometer. Cytometry 33, 362–365.PubMedCrossRefGoogle Scholar
  9. 9.
    Rew, D. A., Reeve, L., and Wilson, G. D. (1998) A comparison of flow and laser scanning cytometry for the measurement of cell proliferation in human solid tumors. Cytometry 33, 355–361.PubMedCrossRefGoogle Scholar
  10. 10.
    Rew, D. A. (2000) In (Darzynkiewicz, Z., Robinson, P. J., and Crissman, H. A., eds.), Cytometry; 3rd ed. Wiley, New York, Chap. 68.Google Scholar
  11. 11.
    Reeve, L. (2000) The development of tumor specific assays for cellular response to anthracycline drugs using laser cytometry. PhD thesis, University of Leicester, UK.Google Scholar
  12. 12.
    Kaur, D. (2002) Investigation of cellular and molecular mechanisms involved in targeted drug delivery systems for human cancers. Doctoral thesis, University of Leicester, UK.Google Scholar
  13. 13.
    Krishan, A. and Sauerteig, A. (1992) Flow cytometric monitoring of cellular resistance to cancer chemotherapy, in Flow Cytometry: Principles and Clinical Application (Bauer, K.D., Duque, R.E., and Shankey, T.V., eds.), Williams and Wilkins, New York, pp. 459–467.Google Scholar
  14. 14.
    Landon, T. M. (1997) Multidrug resistance assays, in Bioprobes, (Landon, T. M., ed.), Molecular Probes, Eugene, OR, pp. 21, 22, 25.Google Scholar
  15. 15.
    Muller, I., Jenner, A., Bruchelt, G., Niethammer, D., and Halliwell, B. (1997) Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem. Biophys. Res. Commun. 230, 254–257.PubMedCrossRefGoogle Scholar
  16. 16.
    Soule, H. D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409–1416.PubMedGoogle Scholar
  17. 17.
    Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., and Cowan, K. H. (1986) Overexpression of a novel anionic glutathione transferase in multidrugresistant human breast cancer cells. J. Biol. Chem. 261, 15544–15549.PubMedGoogle Scholar
  18. 18.
    Woltmann, G., Ward, R. J., Symon, F. A., Rew, D. A., Pavord, I., and Wardlaw, A. J. (1999) Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry. Thorax 54, 124–130.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • David A. Rew
    • 1
  • Gerrit Woltmann
    • 2
  • Davinder Kaur
    • 3
  1. 1.Southampton University HospitalsSouthamptonUK
  2. 2.Glenfield HospitalUniversity of LeicesterUK
  3. 3.Laser Cytometry Facility, Glenfield HospitalUniversity of LeicesterUK

Personalised recommendations